Search research articles
Contact Us
Filters
Showing results (141-150 of 154) with videos related to
Page
of 16
Sort By:
Human Mutation
|
December 23, 2011
A frequent somatic mutation in CD274 3'-UTR leads to protein over-expression in gastric cancer by disrupting miR-570 binding
Weipeng Wang, Jing Sun, Fang Li, et al.
Cell Chemical Biology
|
September 4, 2024
A chemical screen identifies PRMT5 as a therapeutic vulnerability for paclitaxel-resistant triple-negative breast cancer
KeJing Zhang, Juan Wei, SheYu Zhang, et al.
Journal of Genetics and Genomics = Yi Chuan Xue Bao
|
August 25, 2021
Mapping of de novo mutations in primary biliary cholangitis to a disease-specific co-expression network underlying homeostasis and metabolism
Lu Wang, Jinchen Li, Chan Wang, et al.
Clinical Reviews in Allergy & Immunology
|
October 27, 2025
The Genomics/Genetics of Primary Biliary Cholangitis: The Case for a Functional SNP rs10893900 in ETS1/FLI1 and Review of the Literature
Mingming Zhang, Chan Wang, Yexi Huang, et al.
Gastroenterology
|
April 10, 2016
Defective Intestinal Mucin-Type O-Glycosylation Causes Spontaneous Colitis-Associated Cancer in Mice
Kirk Bergstrom, Xiaowei Liu, Yiming Zhao, et al.
Nature Communications
|
August 8, 2024
Blocker-SELEX: a structure-guided strategy for developing inhibitory aptamers disrupting undruggable transcription factor interactions
Tongqing Li, Xueying Liu, Haifeng Qian, et al.
The American Journal of Gastroenterology
|
May 27, 2025
Effect of 3-Day Linaclotide Administration to Reduce the Polyethylene Glycol Volume for Colonoscopy Bowel Preparation: A Multicenter, Noninferiority, Randomized Controlled Trial
Peng Pan, Huixin Chen, Tongchang Wang, et al.
The Lancet. Gastroenterology & Hepatology
|
October 3, 2025
Etrasimod as induction and maintenance treatment for patients with moderately to severely active ulcerative colitis in East Asia (ENLIGHT UC): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study
Kaichun Wu, Changqing Zheng, Qian Cao, et al.
Journal of Gastroenterology and Hepatology
|
January 11, 2013
Gastroesophageal Reflux Disease Questionnaire (GerdQ) in real-world practice: a national multicenter survey on 8065 patients
Yu Bai, Yiqi Du, Duowu Zou, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 26, 2025
Tecotabart vedotin in Claudin 18.2-positive advanced gastric/gastroesophageal junction cancer: A Bayesian phase 1/2 clinical trial
Chunmei Bai, Yi Zheng, Meili Sun, et al.
Page
of 16
Search research articles
Search
Showing results (141-150 of 154) with videos related to
Sort By:
Page
of 16
Human Mutation
|
December 23, 2011
A frequent somatic mutation in CD274 3'-UTR leads to protein over-expression in gastric cancer by disrupting miR-570 binding
Weipeng Wang, Jing Sun, Fang Li, et al.
Cell Chemical Biology
|
September 4, 2024
A chemical screen identifies PRMT5 as a therapeutic vulnerability for paclitaxel-resistant triple-negative breast cancer
KeJing Zhang, Juan Wei, SheYu Zhang, et al.
Journal of Genetics and Genomics = Yi Chuan Xue Bao
|
August 25, 2021
Mapping of de novo mutations in primary biliary cholangitis to a disease-specific co-expression network underlying homeostasis and metabolism
Lu Wang, Jinchen Li, Chan Wang, et al.
Clinical Reviews in Allergy & Immunology
|
October 27, 2025
The Genomics/Genetics of Primary Biliary Cholangitis: The Case for a Functional SNP rs10893900 in ETS1/FLI1 and Review of the Literature
Mingming Zhang, Chan Wang, Yexi Huang, et al.
Gastroenterology
|
April 10, 2016
Defective Intestinal Mucin-Type O-Glycosylation Causes Spontaneous Colitis-Associated Cancer in Mice
Kirk Bergstrom, Xiaowei Liu, Yiming Zhao, et al.
Nature Communications
|
August 8, 2024
Blocker-SELEX: a structure-guided strategy for developing inhibitory aptamers disrupting undruggable transcription factor interactions
Tongqing Li, Xueying Liu, Haifeng Qian, et al.
The American Journal of Gastroenterology
|
May 27, 2025
Effect of 3-Day Linaclotide Administration to Reduce the Polyethylene Glycol Volume for Colonoscopy Bowel Preparation: A Multicenter, Noninferiority, Randomized Controlled Trial
Peng Pan, Huixin Chen, Tongchang Wang, et al.
The Lancet. Gastroenterology & Hepatology
|
October 3, 2025
Etrasimod as induction and maintenance treatment for patients with moderately to severely active ulcerative colitis in East Asia (ENLIGHT UC): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study
Kaichun Wu, Changqing Zheng, Qian Cao, et al.
Journal of Gastroenterology and Hepatology
|
January 11, 2013
Gastroesophageal Reflux Disease Questionnaire (GerdQ) in real-world practice: a national multicenter survey on 8065 patients
Yu Bai, Yiqi Du, Duowu Zou, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 26, 2025
Tecotabart vedotin in Claudin 18.2-positive advanced gastric/gastroesophageal junction cancer: A Bayesian phase 1/2 clinical trial
Chunmei Bai, Yi Zheng, Meili Sun, et al.
Page
of 16